About Burning Rock Biotech Limited
https://www.brbiotech.comBurning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
CEO
Yusheng Han
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-05-15 | Reverse | 1:10 |
| 2014-08-01 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 19
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
KYNAM CAPITAL MANAGEMENT, LP
Shares:994.88K
Value:$28.37M
CRCM LP
Shares:221.57K
Value:$6.32M
PICTET ASSET MANAGEMENT LTD
Shares:49K
Value:$1.4M
Summary
Showing Top 3 of 20
About Burning Rock Biotech Limited
https://www.brbiotech.comBurning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $131.62M ▼ | $114.97M ▼ | $-16.76M ▼ | -12.73% ▼ | $-15.6 ▼ | $-3.28M ▼ |
| Q2-2025 | $148.55M ▲ | $119.6M ▲ | $-9.7M ▲ | -6.53% ▲ | $-9 ▲ | $1.35M ▲ |
| Q1-2025 | $133.08M ▲ | $112.58M ▼ | $-13.5M ▲ | -10.14% ▲ | $-12.5 ▲ | $-15.18M ▲ |
| Q4-2024 | $126.02M ▼ | $171.35M ▲ | $-81.29M ▼ | -64.51% ▼ | $-78.7 ▼ | $-46.8M ▼ |
| Q3-2024 | $128.64M | $130.44M | $-35.74M | -27.79% | $-34.6 | $-5.73M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $463.99M ▲ | $812.17M ▼ | $262.59M ▲ | $549.58M ▼ |
| Q2-2025 | $452.72M ▼ | $824.93M ▼ | $260.7M ▼ | $564.24M ▼ |
| Q1-2025 | $495.14M ▼ | $854.72M ▼ | $282.92M ▼ | $571.8M ▼ |
| Q4-2024 | $519.85M ▲ | $885.3M ▼ | $304.48M ▼ | $580.83M ▼ |
| Q3-2024 | $497.97M | $984.8M | $336.64M | $648.17M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-16.76M ▼ | $16.39M ▲ | $-2.75M ▼ | $0 ▼ | $11.96M ▲ | $16.39M ▲ |
| Q2-2025 | $-9.7M ▲ | $-44.35M ▼ | $207K ▲ | $2M ▲ | $-42.38M ▼ | $-44.35M ▼ |
| Q1-2025 | $-13.5M ▼ | $-23.53M ▼ | $-1.53M ▼ | $0 ▲ | $-24.76M ▼ | $-23.53M ▼ |
| Q4-2024 | $0 | $19.06M ▲ | $-812K ▲ | $-74K ▼ | $23.91M ▲ | $13.64M ▲ |
| Q3-2024 | $0 | $-30.28M | $-987K | $2K | $-34.8M | $-30.28M |
Revenue by Products
| Product | Q2-2022 | Q4-2022 |
|---|---|---|
 Product | $80.00M ▲ | $90.00M ▲ |
 Service | $190.00M ▲ | $210.00M ▲ |
CEO
Yusheng Han
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-05-15 | Reverse | 1:10 |
| 2014-08-01 | Reverse | 1:3 |
ETFs Holding This Stock
Summary
Showing Top 3 of 19
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
KYNAM CAPITAL MANAGEMENT, LP
Shares:994.88K
Value:$28.37M
CRCM LP
Shares:221.57K
Value:$6.32M
PICTET ASSET MANAGEMENT LTD
Shares:49K
Value:$1.4M
Summary
Showing Top 3 of 20